Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Roche was unveiled new Phase 1 and 2 data for entrectinib in the treatment of locally advanced or metastatic ROS1-positive non-small cell lung...
AstraZeneca and its global biologics R&D arm MedImmune have announced the approval by the European Commission of Imfinzi (durvalumab) as a...
The number of new HIV diagnoses is on the rise among heterosexual men in Australia, according to a new report released by the Kirby Institute.
Sarepta Therapeutics has revealed that its therapy Exondys 51 (eteplirsen) has been slapped with a negative opinion by the European Medicines...
The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block Britain’s National...
Life expectancy  has fallen for the second year in a row for people in the United States, according to new data released by Centers for...
AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings in...
The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing...
To find out more, check out this week’s Top 10 most popular articles on Pharmafile.com now!
The Congressional Budget Office (CBO) has said in a report that a bipartisan bill awaiting a vote in the senate would allow generic versions of...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches